Mesalamine and relapse prevention in Crohn's disease

Slides:

Advertisements

Similar presentations

Celiac disease–like abnormalities in a subgroup of patients with irritable bowel syndrome Ulrich Wahnschaffe, R. Ullrich, E.O. Riecken, J.D. Schulzke Gastroenterology.

Advertisements

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Celiac Disease Genetics: Current Concepts and Practical Applications Ludvig M. Sollid, Benedicte A. Lie Clinical Gastroenterology and Hepatology Volume.

Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.

Interleukin 15 mediates epithelial changes in celiac disease Luigi Maiuri, Carolina Ciacci, Salvatore Auricchio, Virginia Brown, Sonia Quaratino, Marco.

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease Richard N. Fedorak, *, Alfred Gangl, ‡, Charles.

Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice Debra G. Silberg, Jessica Sullivan, Eugene Kang, Gary P. Swain, Jennifer.

Volume 123, Issue 2, Pages (August 2002)

Masatoshi Kudo Clinical Gastroenterology and Hepatology

It's time to bring the best and brightest back to gastroenterology!

Volume 122, Issue 1, Pages (January 2002)

Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F

Volume 122, Issue 3, Pages (March 2002)

Diagnosis of irritable bowel syndrome

Efficacy of Topical 5-Aminosalicylates in Preventing Relapse of Quiescent Ulcerative Colitis: A Meta-analysis Alexander C. Ford, Khurram J. Khan, William.

Volume 119, Issue 2, Pages (August 2000)

Leptin, obesity, and liver disease

Volume 122, Issue 1, Pages (January 2002)

Polyxeni Koutkia, Zhiren Lu, Tai C. Chen, Michael F. Holick

Psychiatric disorders among veterans with hepatitis C infection

Volume 124, Issue 4, Pages (April 2003)

Volume 123, Issue 6, (December 2002)

Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis

Spreading and focusing of gluten epitopes in celiac disease

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families Paul D.P. Pharoah,

Risks and Benefits of Infliximab for the Treatment of Crohn’s Disease

Appendectomy is followed by increased risk of Crohn's disease

Volume 123, Issue 2, Pages (August 2002)

Volume 123, Issue 2, Pages (August 2002)

Oral pentasa in the treatment of active Crohn’s disease: A meta-analysis of double- blind, placebo-controlled trials Stephen B Hanauer, Ulf Strömberg

Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C Chi–Jen Chu, Munira Hussain,

In This Issue Cell Volume 158, Issue 5, (August 2014)

Antje Timmer*, Lloyd R. Sutherland*,‡, Francois Martin§

Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis Zobair M. Younossi Clinical.

Volume 123, Issue 5, Pages (November 2002)

Volume 120, Issue 4, Pages (March 2001)

Volume 123, Issue 2, Pages (August 2002)

Yousef Rezaei, MD American Journal of Kidney Diseases

Volume 118, Issue 2, Pages (February 2000)

Protein-Losing Enteropathy in Crohn’s Disease

J. Ranstam Osteoarthritis and Cartilage

Volume 122, Issue 7, Pages (June 2002)

Issue Highlights Clinical Gastroenterology and Hepatology

Lise L. Kjaergard, Sarah L. Frederiksen, Christian Gluud

AGA technical review on nonalcoholic fatty liver disease

Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease Gerassimos J.

Psychiatric disorders among veterans with hepatitis C infection

Volume 121, Issue 5, Pages (November 2001)

Image of the month Gastroenterology

Volume 135, Issue 5, Pages (November 2008)

Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk E.Jan Irvine, John K. Marshall Gastroenterology

Reinduction With Certolizumab Pegol in Patients With Relapsed Crohn's Disease: Results From the PRECiSE 4 Study William J. Sandborn, Stefan Schreiber,

Volume 119, Issue 4, Pages (October 2000)

Volume 121, Issue 5, Pages (November 2001)

Chronic Diarrhea Clinical Gastroenterology and Hepatology

Moynihan of Moynihan's “hunger pain”

AGA technical review on osteoporosis in gastrointestinal diseases

KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target American.

Volume 128, Issue 7, Pages (June 2005)

Janusz A. Jankowski, Dawn Provenzale, Paul Moayyedi Gastroenterology

Clinical Gastroenterology and Hepatology

Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism? John S. Leeds, David S. Sanders

Masatoshi Kudo Clinical Gastroenterology and Hepatology

Gastroenterology Volume 124, Issue 4, (April 2003) DOI: /S (03)

Matthew J. Lee, Claire E. Parker, Sarah R

Predictors of response to infliximab in patients with Crohn's disease

Medical Therapy for Refractory Pediatric Crohn’s Disease

Volume 121, Issue 2, Pages (August 2001)

Angiomyolipoma of the Colon

Covering the Cover Gastroenterology

Presentation transcript:

Mesalamine and relapse prevention in Crohn's disease Mario Cottone, Calogero Cammà Gastroenterology Volume 119, Issue 2, (August 2000) DOI: 10.1053/gast.2000.16153 Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 1 Meta-analysis of 5 RCTs with surgically induced remission of mesalamine for prevention of clinical relapse in quiescent Crohn's disease. Cumulative risk difference and respective 95% confidence intervals are plotted on the graph. Studies are arranged by publication year. Gastroenterology 2000 119, DOI: (10.1053/gast.2000.16153) Copyright © 2000 American Gastroenterological Association Terms and Conditions